Cairns Health Professionals Dinner: Bispecifics and CAR T-Cell Therapy in Lymphoma

WE HAVE NOW REACHED CAPACITY FOR THIS EVENT
Please email nurse@lymphoma.com.au to be added to the Waitlist

Join us for dinner and learn about the latest in Bispecifics and CAR T-Cell Therapy for Lymphoma.

Guest Speakers

Dr. Alana Gedrose

Dr. Alana Gedrose is a Clinical and Laboratory Haematologist at Cairns Hospital, with previous experience at Gold Coast University Hospital and Calvary Mater/John Hunter Hospital in Newcastle. She has a background in both general and malignant haematology, with expertise in clinical trials, CAR T-cell therapies (CART), and autologous stem cell transplants. Dr. Gedrose is dedicated to providing high-quality care to patients in regional and remote areas.

Kylie Grevell

Kylie is a Clinical Nurse Consultant in Haematology/Oncology at Cairns Hospital, where she has worked for the past 13 years. With 18 years of Cancer Nursing experience, Kylie holds a postgraduate certificate in Cancer Nursing and brings extensive expertise in managing complex haematology patients in regional and rural settings. She is passionate about improving access to cancer treatment for patients living outside metropolitan areas and advocates for delivering care closer to home.

Agenda

ARRIVAL	6pm
Presentation 1	615-630pm	Welcome Address by Kirsty Wyer: Lymphoma Care Nurse
Presentation 2	645-730pm	Dr. Alana Gedrose, Haematologist: CAR T-Cell Therapy in a Regional Setting
Presentation 3	745-830pm	Kylie Grevell, CNC: Bispecifics and Treatment Management in a Regional Setting
Q & A	830-845pm	Q& A Discussion
MEETING CLOSE	9pm	Travel Home Safely

Salt House Location

There is limited availability for this event, so secure your spot quickly.

This event has already taken place.

Details

Date: Tuesday 2nd of September 2025

Time: 6:00pm AEST - 9:00pm AEST

Location: Salt House
Marina Point, 6/2 Pier Point Rd, Cairns QLD 4870

This event has reached capacity, if you would like to be added to the Waitlist please email nurse@lymphoma.org.au

Support and information

Patient Online Forum

Find Out More

Order Our Resources

Find Out More

Fundraise for us

Get started

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
Relapsed: This means the lymphoma came back after being gone for a while after treatment.
2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here.

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.